About Us
Administration
Alumni
Awards & Rankings
Diversity
In Memoriam
Latham Sustainability
Media Coverage
News
Pro Bono & Community Service
Retired Partners
Women Enriching Business
Online Resources
Languages
中文
Deutsch
English
Español
Français
Italiano
日本語
한국어
People Finder
Find a person by name or search via surname initial
Quick search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Industries
Latham & Watkins meets clients’ needs by understanding the industries in which they operate.
IN THIS SECTION
Aerospace, Defense & Government Services
Automotive
Energy & Infrastructure
Entertainment, Sports & Media
Financial Institutions
Fintech
Healthcare & Life Sciences
Hospitality, Gaming & Leisure
REITs
Retail & Consumer Products
Technology
Video Gaming & esports
Go to Industries Section
Practices
Activism Defense
Africa Practice
Antitrust & Competition
Australia Practice
Banking
Bankruptcy Litigation & Creditors’ Rights
Capital Markets
CFIUS & US National Security
Climate Change
Communications Law
Complex Commercial Litigation
Connectivity, Privacy & Information
Corporate Governance
Data Privacy & Security
Derivatives
Direct Lending & Private Debt
Emerging Companies
Entertainment, Sports & Media
Environment, Land & Resources
Environmental, Social & Governance (ESG)
Executive Compensation, Employment & Benefits
Export Controls, Economic Sanctions & Customs
Financial Regulatory
Government Contracts
Greater China Practice
Healthcare & Life Sciences
India Practice
Indonesia Practice
Insurance Counseling & Recovery
Intellectual Property Litigation
International Arbitration
Investment Funds
Islamic Finance
Israel Practice
Korea Practice
Latin America Practice
Litigation & Trial Practice
Mergers & Acquisitions
Nordic Practice
Outsourcing
Payments & Emerging Financial Services
Philippines Practice
Private Capital
Private Equity
Private Equity Finance
Product Liability, Mass Torts & Consumer Class Actions
Project Development & Finance
Public Company Representation
Real Estate
Restructuring & Special Situations
Securities Litigation & Professional Liability
Special Purpose Acquisition Companies (SPACs)
Structured Finance
Supreme Court & Appellate
Tax
Tax‐free Spin‐offs
Technology Transactions
Thailand Practice
Vietnam Practice
White Collar Defense & Investigations
Go to Practices Section
Knowledge Library
Latham & Watkins provides first-class thought leadership across practices and industries, locally and globally.
IN THIS SECTION
Blogs
Book of Jargon® Series & Other Apps
Events
Thought Leadership
Videos
Webcasts & Podcasts
VIDEO
NFTs 101: The Basics of Non-Fungible Tokens, and Beyond
Learn about 2021’s defining cryptoasset in a new infographic video and webcast, the latest in a Latham series covering NFTs.
view
UPCOMING EVENT
Private Equity and Healthcare: Enforcement Trends and Investor Risk
Latham attorneys discuss enforcement priorities across the healthcare and life sciences private equity space, as well as key areas of investor risk. MCLE credit offered.
Webcast
Read more
Go to Knowledge Library
Global Directory
Located in business centers across the globe, the lawyers of Latham & Watkins come from all regions of the world to practice within its fully integrated, one-firm structure.
IN THIS SECTION
Find Our People
Latham Around the World - List View
Our Offices
Our People
Join Us
Events
close x
January 2000
Jan
Feb
Mar
Apr
Su
Mo
Tu
We
Th
Fr
Sa
Home
|
Knowledge Library
|
Thought Leadership
Blogs
Book of Jargon® Series & Other Apps
Events
Thought Leadership
Videos
Webcasts & Podcasts
Search Thought Leadership
To refine your search select a single option or a combination of options:
Select an Industry
Aerospace, Defense & Government Services
Automotive
Energy & Infrastructure
Entertainment, Sports & Media
Financial Institutions
Fintech
Healthcare & Life Sciences
Hospitality, Gaming & Leisure
Information Technology – Systems & Solutions
Infrastructure
Internet & Digital Media
Mining & Metals
Oil & Gas
Power
REITs
Renewable Energy
Retail & Consumer Products
Semiconductors
Technology
Video Gaming & esports
Select a Practice
Accountants' & Professional Liability
Activism Defense
Africa Practice
Air Quality
Antitrust & Competition
Banking
California Energy
California Environmental Litigation
California Environmental, Land & Resources
California Project Siting & Approvals
Capital Markets
CFIUS & US National Security
Chemical Regulation & Product Defense
China Environmental
Climate Change
Commodities and Derivatives Regulation and Enforcement
Communications Law
Complex Commercial Litigation
Contaminated Properties & Waste
Corporate Governance
Data Privacy & Security
Derivatives
Direct Lending & Private Debt
Dodd-Frank & The Consumer Financial Protection Bureau
Emerging Companies
Energy Regulatory & Markets
Entertainment, Sports & Media
Environment, Land & Resources
Environmental Insurance Counseling & Recovery
Environmental Litigation
Environmental Transactions
Environmental, Social & Governance (ESG)
European Environmental & Public Law
Executive Compensation, Employment & Benefits
Export Controls, Economic Sanctions & Customs
FDA Regulatory
Financial Regulatory
Government Contracts
Greater China Practice
Healthcare & Life Sciences
India Practice
Indonesia Practice
Insurance Counseling & Recovery
Intellectual Property Appeals
Intellectual Property Litigation
International Arbitration
International Tax
International Trade Commission (ITC) Patent Litigation
Investment Funds
Islamic Finance
Israel Practice
Korea Practice
Latin America Practice
Life Sciences Licensing
Litigation & Trial Practice
Master Limited Partnerships
Mergers & Acquisitions
Mergers & Acquisitions Litigation
Mining
Nordic Practice
Oil & Gas – Environmental
Patent Litigation
Payments & Emerging Financial Services
Power
Power Generation
Private Capital
Private Equity
Private Equity Finance
Product Liability, Mass Torts & Consumer Class Actions
Product Liability, Mass Torts & Consumer Class Actions – Environmental
Project Development & Finance
Project Siting & Approvals
Public & Tax-Exempt Finance
Public Company Representation
Real Estate
Restructuring & Special Situations
Securities Litigation & Professional Liability
Shareholder & Derivative Litigation Defense
Special Purpose Acquisition Companies (SPACs)
Structured Finance
Supreme Court & Appellate
Sustainable Finance
Tax
Tax Controversy
Tax-Exempt Organizations
Technology Transactions
Tokenization and Blockchain Technology
Transactional Tax
US Tax Reform Resource Center
Water
Water Quality
Water Supply
White Collar Defense & Investigations
Select a Region
Africa
Asia
Europe
Latin America
North America
US
Select an Office
Austin
Beijing
Boston
Brussels
Century City
Chicago
Dubai
Düsseldorf
Frankfurt
Hamburg
Hong Kong
Houston
London
Los Angeles
Madrid
Milan
Moscow
Munich
New York
Orange County
Paris
Riyadh
San Diego
San Francisco
Seoul
Shanghai
Silicon Valley
Singapore
Tokyo
Washington, D.C.
Select a Date Range
Last 30 Days
Last 90 Days
2021
2020
2019
2018
2017
2016
Find
reset
THOUGHT LEADERSHIP
Displaying Thought Leadership item(s) about Healthcare & Life Sciences
Show
10
|
50
|
100
|
All
results per page
1
/
2
/
3
/
4
/
5
Next
231 results
December 06, 2021
Healthcare & Life Sciences: Drug Pricing Digest
Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
share
view
November 24, 2021
UK’s MHRA Seeks “Bold New Regulatory Regime” for Medical Devices and Diagnostics
The agency’s consultation on the post-Brexit regulatory framework for medical devices and diagnostics aims to support innovation and sustainability, among other goals.
share
view
November 22, 2021
Healthcare & Life Sciences: Drug Pricing Digest
Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
share
view
November 08, 2021
Healthcare & Life Sciences: Drug Pricing Digest
Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
share
view
October 25, 2021
Healthcare & Life Sciences: Drug Pricing Digest
Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
share
view
October 11, 2021
Healthcare & Life Sciences: Drug Pricing Digest
Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
share
view
September 27, 2021
Healthcare & Life Sciences: Drug Pricing Digest
Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
share
view
September 13, 2021
Healthcare & Life Sciences: Drug Pricing Digest
Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
share
view
August 30, 2021
Healthcare & Life Sciences: Drug Pricing Digest
Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
share
view
August 16, 2021
Healthcare & Life Sciences: Drug Pricing Digest
Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
share
view
Show
10
|
50
|
100
|
All
results per page
1
/
2
/
3
/
4
/
5
Next
The cookies we use
Latham & Watkins uses cookies which are essential for the operation of our website. We would also like to use analytics cookies to help us understand how visitors use our site so we can continue to improve it, but we will only do so with your consent. We use a cookie to remember your preferences. You can access and change your preferences at any time by clicking on the gear icon.
Essential cookies
Essential cookies enable the core functionality of our website such as security, authentication, and accessibility. You can change your browser settings to disable these cookies, but it may affect your ability to access and use the site.
Analytics cookies
We would like to use Google Analytics to analyse how visitors interact with our site so that we can continue to develop and improve it. These services are provided in Europe by Google Ireland Limited and elsewhere by Google LLC and affiliated Google Entities. Google Analytics uses cookies to collect information about visitors to our site (data related to the device/browser, IP address and on-site activity). They measure and report on user interactions, such as the volume and nature of visits to our site. If you agree to the use of these analytics cookies, please move the slider to “On.” Please refer to the
Cookies Policy
on our
Privacy
page
for more information.
Save and close
© 2021 Latham & Watkins
Prior results do not guarantee a similar outcome.
Attorney Advertising & Terms of Use
|
Mobile Site
|
Privacy
|
Site Map
Email Scam Warning
|
Latham & Watkins LLP has office locations in Austin, Beijing, Boston, Brussels, Century City, Chicago, Dubai, Düsseldorf, Frankfurt, Hamburg, Hong Kong, Houston, London, Los Angeles, Madrid, Milan, Moscow, Munich, New York, Orange County, Paris, Riyadh,* San Diego, San Francisco, Shanghai, Seoul, Silicon Valley, Singapore, Tel Aviv, Tokyo, and Washington, D.C.
*In cooperation with the Law Office of Salman M. Al-Sudairi
Notice:
We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.
Cancel
Accept